Search

Search Constraints

You searched for: Author/Creator Loza, Matthew

Search Results

1. "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Issue 1 (3rd January 2019)

3. Clinical and transcriptomic features of persistent exacerbation‐prone severe asthma in U‐BIOPRED cohort. Issue 4 (26th April 2022)

4. Contribution of airway eosinophils in airway wall remodeling in asthma: Role of MMP‐10 and MET. Issue 6 (11th February 2019)

5. Instability of sputum molecular phenotypes in U-BIOPRED severe asthma. Issue 2 (4th February 2021)

6. Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis. Issue 5 (3rd May 2018)

7. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Issue 2 (9th February 2017)

8. Type 2‐low asthma phenotypes by integration of sputum transcriptomics and serum proteomics. Issue 1 (16th September 2020)

9. Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study. Issue 6 (30th June 2022)

10. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study. Issue 1 (December 2016)